Mitochondria and Antibiotics: For Good or for Evil?

Area of Science:

• Medical Science
• Pharmacology
• Microbiology

Background:

• Antibiotics revolutionized medicine, reducing infectious disease mortality and increasing life expectancy.
• Extensive antibiotic use has led to a global rise in antibiotic resistance.
• Emerging evidence suggests antibiotics can harm mammalian mitochondria, prompting caution in their clinical application.

Purpose of the Study:

• To review the current understanding of antibiotic therapies.
• To discuss the controversy surrounding antibiotic use beyond severe infections.
• To explore potential benefits of antibiotics in treating diverse conditions like cancer and neurodegenerative diseases.

Main Methods:

• Literature review of recent studies on antibiotic therapies.
• Analysis of evidence regarding antibiotic risks, including mitochondrial toxicity.
• Discussion of findings supporting novel therapeutic applications of antibiotics.

Main Results:

• Antibiotics are a double-edged sword, offering benefits but posing risks like resistance and mitochondrial damage.
• Despite risks, research indicates potential therapeutic value in conditions beyond infections.
• Significant debate exists regarding the risk-benefit ratio of current and novel antibiotic applications.

Conclusions:

• The clinical application of antibiotics requires careful consideration of both established benefits and emerging risks.
• Further research is crucial to balance the advantages of antibiotic use against the threat of resistance and potential side effects.
• The therapeutic potential of antibiotics in non-infectious diseases warrants continued investigation and clinical evaluation.